Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
MRNX ETF — Defiance Daily Target 2X Long MRNA ETF
Defiance Daily Target 2X Long MRNA ETF (MRNX)
Updated October 16, 2026.
MRNX is an ETF linked to Moderna (MRNA). its expense ratio is 1.34%. Total return is 725.8% over the past 0.7 years, 316.1 points ahead of MRNA at 409.7%.
This is an actively managed ETF that seeks to deliver twice the daily percentage change of Moderna's stock price through the use of derivatives such as swap agreements and listed options contracts. The fund is non-diversified and carries a 1.34% expense ratio. It is designed for traders seeking leveraged exposure to Moderna on a daily basis rather than for long-term income investors.
MRNX holdings and sector exposure
Holdings are not available for this snapshot.
Economic / reference exposure: MRNA (physical holdings below may be collateral and options, not the reference asset itself).
MRNX performance versus MRNA
Price and return data through 2026-10-16.
Total return is 725.8% over the past 0.7 years, 316.1 points ahead of MRNA at 409.7%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 102.2% | — |
| 3M | 410.2% | — |
| 6M | 461.2% | — |
| YTD | 725.8% | — |
| Since inception (0.7 years) | 725.8% | — |
MRNX key facts
- Issuer
- Defiance ETFs
- Asset type
- ETF
- Asset class
- Equity
- Expense ratio
- 1.34%
- Distribution frequency
- None
- Last close
- $168.30 (as of 2026-10-16)
- AUM
- $55,138,123
- Average volume
- 365900.0
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: Defiance ETFs or company page; Index: Moderna (MRNA); prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
Who may consider MRNX — and who may not
It is a weaker fit for investors who need monthly cash flow (MRNX does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on MRNX
Frequently asked questions
Does MRNX pay monthly?
No. MRNX does not currently distribute.
What is MRNX linked to?
MRNX is linked to Moderna (MRNA), not a broad market index.
What is MRNX's expense ratio?
MRNX's expense ratio is 1.34%.
When does MRNX pay a dividend?
MRNX does not currently distribute.
How has MRNX performed?
Total return is 725.8% over the past 0.7 years, 316.1 points ahead of MRNA at 409.7%.
More securities from Defiance ETFs.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.